Skip to content

Comparison two methods of oxytocin use after delivery

Comparison two methods of oxytocin use after delivery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT138812043413N1
Enrollment
200
Registered
2010-04-15
Start date
2007-01-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

control of third stage. Third-stage haemorrhage

Interventions

Intervention 1: Oxytocin, 10 unit as bolus after delivery. Intervention 2: Oxytocin, 10 IU infusion in 500 cc normal saline with a rate of 125 cc/h.
Prevention
Oxytocin, 10 unit as bolus after delivery
Oxytocin, 10 IU infusion in 500 cc normal saline with a rate of 125 cc/h

Sponsors

Kashan University of Medical Sciences, Vice-chancellor for Research
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: woman with vaginal delivery after 20 week gestation without instrumentation, age between 18 and 40 yrs, singleton pregnancies, parity equal or less than 5, Iranian nationality. Exclusion criteria: Allergy to oxytocin, Presence of any medical or obstetric diseases (including pregnancy-induced hypertension disorders, hypertention, heart diseases, coagulation disorder), known risk factors for postpartum haemorrhage (including abnormal placentation, uterine fibroids, history of postpartum hemorrhage or uterine atony, polyhydramnious , clinical chorioamnionitis , precipitant labor)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Maternal pulse rate and blood pressure. Timepoint: At the admission time and 1, 5, 10, 20 min after delivery. Method of measurement: Maternal pulse rate per mim and blood pressure left hand by using mercury mannometer in supine position by obstetric and gynecologist resident physician.

Secondary

MeasureTime frame
Third stage delivery outcome. Timepoint: Immediately after delivery to half an hour for duration of third stage and placenta retention, an hour after delivery for determination of additional uterotonic agent and Hb at the admission time and 6 hours after delivery. Method of measurement: Maternal pulse rate per mim and blood pressure of left hand by using mercury mannometer in supine position by obstetric and gynecologist resident physician.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Fatameh Foroozanfard

Kashan University of Medical Sciences

fatemehforoozanfard@yahoo.com+98 36 1446 0180

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026